Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Background: MCC is a rare, cutaneous, neuroendocrine tumor. MCC is an aggressive disease associated with frequent locoregional recurrences and visceral metastases, and a high mortality rate. This retrospective observational study aimed to assess treatment outcomes among second line (2L) or later chemotherapy in a real-world setting to better understand treatment pathways and prognosis in distant metastatic MCC patients (pts).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
